JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Predicting cancer detection rates from multiparametric prostate MRI Beyond the PI-RADS classification system

  • 0Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, MA, United States.
Canadian Urological Association Journal = Journal De L'association Des Urologues Du Canada +

|

November 11, 2024

|

November 11, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

A new predictive model using clinical and radiographic features improves prostate cancer detection rates from MRI-targeted biopsies. This model outperforms the standard strategy of biopsying all PI-RADS 3-5 lesions, aiding clinical decisions.

Area Of Science

  • Urology
  • Radiology
  • Oncology

Background

  • Prostate Imaging-Reporting and Data System (PI-RADS) is standard for prostate cancer risk assessment via MRI.
  • Real-world prostate cancer detection rates (CDRs) vary significantly despite PI-RADS.
  • This study aimed to identify factors influencing CDRs and develop a predictive model.

Purpose Of The Study

  • To evaluate associations between clinical/radiographic features and cancer detection rates (CDRs) in prostate MRI.
  • To develop a predictive model for improved clinical management of prostate cancer.

Main Methods

  • Analysis of men (18-89 years) with elevated PSA or active surveillance undergoing MRI-US fusion or in-bore MRI-targeted biopsy.
  • Logistic regression examined associations of features with per-lesion CDR (Gleason 6-10) and clinically significant (cs) CDR (Gleason 7-10).
  • A predictive model was operationalized based on identified associations.

Main Results

  • 347 lesions in 281 patients underwent targeted biopsy; overall CDR was 49.0%, csCDR was 28.0%.
  • Higher PI-RADS category, smaller prostate size, and higher PSA density correlated with increased CDR.
  • Prior biopsy was linked to lower CDR; solitary PI-RADS 3-5 lesions and fewer prior biopsies increased csCDR.

Conclusions

  • Clinical and radiographic features independently predict prostate cancer risk in MRI-targeted biopsies.
  • A developed predictive model enhances biopsy decisions over the standard PI-RADS 3-5 lesion strategy.
  • The model offers improved clinical decision-making for prostate cancer diagnosis.